Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2021) 73 AEP770 | DOI: 10.1530/endoabs.73.AEP770

Farhat Hached Sousse, Endocrinology, Tunisia


Introduction

Acromegaly is a rare disease, but serious in its complications. It is a multisystemic pathology also affecting the thyroid. The aim of our work is to study thyroid involvement in acromegaly.

Patients and methods

This is a retrospective study of acromegalic patients, in the endocrinology department of Sousse over a period of 20 years.

Result

These are 40 acromegaly patients, with a sex ratio (M/F) of 0.74. The mean age was 38.9 years [13-77]. The mean IGF1 level was 937 ng/ml [367–1700]. Anterior pituitary insufficiency was present in 32.5% of cases and thyrotropic insufficiency in 17.5% of cases. Thyroid ultrasound was performed in 20 patients. It was normal in 12 patients (60%). A multi-nodular goiter was found in a quarter of the cases and it was indicative of the disease in one case. Nodules on a normal-sized thyroid were found in 20% of cases. Fine needle aspiration was performed in two patients, showing a benign appearance. A thyroid scintigraphy done in three patients showed one cold and two hot nodules. There was no correlation between the level of IGF1 and the onset of goiter.

Discussion and conclusion

It is well established that acromegaly can affect pituitary function, including the thyrotropic axis. On the other hand, it is associated with an increased prevalence of goiter, as thyroid follicular cells express IGF-I receptors. Studies suggest a positive relationship between thyroid volume and elevated serum IGF-I levels. Hence the interest of a systematic exploration of the thyroid to the discovery of acromegaly and during the follow-up.

Volume 73

European Congress of Endocrinology 2021

Online
22 May 2021 - 26 May 2021

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts